Phase 2 study evaluating efficacy and safety of everolimus with letrozole in advanced (unresectable or metastatic) non-small cell lung cancer (NSCLC) after failure of platinum-based treatment: A preliminary analysis of toxicity.
2014 ◽
Vol 32
(15_suppl)
◽
pp. e19089-e19089
Keyword(s):
Phase 2
◽
2015 ◽
Vol 93
(4)
◽
pp. 757-764
◽